The electrophoretic pattern of laddered DNA frag ments which has been observed after cerebral ischemia is con sidered to indicate that neurons are dying by apoptosis. Herein the authors directly demonstrate using ligation-mediated poly merase chain reaction methods that 99% of the DNA fragments produced after either global or focal ischemia in adult rats, or produced after hypoxia-ischemia in neonatal rats, have stag
gered ends with a 3' recess of approximately 8 to 10 nucleo tides. This is in contrast to archetypal apoptosis in which the DNA fragments are blunt ended as seen during developmental Despite its initial description as long ago as 1980 (Wyllie et aI., 1980) , an electrophoretic laddered pattern of DNA fragments remains the premier biochemical hall mark of an apoptotic mode of cell death (Bortner et aI., 1995; Choi, 1996; Walker and Sikorska, 1997) . How ever, some exceptions have been noted, for example in neonatal brain after excitotoxicity (van Lookeren Cam pagne et aI., 1995) , that prevent the sole use of this criterion as conclusive evidence of apoptosis. This elec trophoretic pattern arises from the cleavage of the linker DNA between nucleosomes in chromatin, resulting in oligomeric fragments of unit size of approximately 180 base pairs (bp). The occurrence of such internucleosomal cleavage has been documented in a wide variety of cells and tissues induced to die by a myriad of insults. The endonuclease responsible for the ordered scission of the DNA backbone remains unknown, but several candidates such as DNase I or II and Nuc 18 have been proposed over the years (Bortner et aI., 1995; Walker and Sikor ska, 1997) .
programmed cell death in dying cortical neurons, neuroblas toma, or thymic lymphocytes. It is not simply ischemia that results in staggered ends in DNA fragments because ischemic myocardium is similar to archetypal apoptosis with a vast ma jority of blunt-ended fragments. It is concluded that the endo nucleases that produce this staggered fragmentation of the DNA backbone in ischemic brain must be different than those of classic or type I apoptosis. Key Words: Ischemia-Stroke Apoptosis-DNA fragmentation-Endonuclease-LM-PCR.
Neurons have the capacity to die by apoptosis and do so in huge numbers during fetal and early postnatal de velopment as supernumerary precursor neuroblasts are culled during synapse formation. The programmed cell death of such immature neurons is considered to be apoptotic because they exhibit both the morphologic characteristics of marginated chromatin and karyorrhexis (Lo et aI., 1995) and the biochemical characteristic of laddered DNA fragmentation (Ferrer et aI., 1994; Blas chke et aI., 1996; Portera-Cailliau et aI., 1997a) .
To date there have been numerous reports showing electrophoretic patterns of laddered DNA fragments from either ischemic brain or other neurodegenerative situations (reviewed by Choi, 1996; Chopp and Li, 1996; Linnik, 1996; MacManus and Linnik, 1997) , which has led to the conclusion that cerebral ischemia induces ap optosis of brain cells. This is despite the fact that, in general, ischemic neurons do not display the morpho logic characteristics of apoptosis (Deshpande et aI., 1992; van Lookeren-Campagne and Gill, 1996; Petito et aI., 1997) , although there are exceptions (Endres et aI., 1998; States et aI., 1996) , particularly in the boundary zone on the edge of the infarcted brain after a focal ischemic insult (Charriault-Marlangue et aI., 1996; Li et a!., 1995) . The laddered DNA fragmentation seen after cerebral ischemia has been considered apoptotic for sev-eral reasons. First, the fragments appear as oligomers of approximate unit size of 180 to 200 bp, which is similar to classic apoptosis (reviewed by Choi, 1996; Chopp and Li, 1996; Linnik, 1996; MacManus and Linnik, 1997) . Second, the fragmentation is different from the random cleavage of necrosis (Tominaga et ai., 1993; MacManus et ai., 1995) . Third, there is a clear involvement of the apoptotic proteolytic cascade of caspases enzymes after cerebral ischemia (Endres et aI., 1998; Namura et aI., 1998) . In a similar vein, oligonucleosomal DNA frag mentation indicative of apoptosis has been described in tissue from ischemic rodent and human heart (Fliss and Gattinger, 1996; Veinot et aI., 1997) .
Other than noting the common oligonucleosomal size of apoptotic fragments in all dying cells studied, the na ture of the ends of the DNA fragments has received scant attention. Alnemri and Litwack (1990) demonstrated that apoptotic cultured human lymphocytes displayed inter nucleosomal cleavage with blunt-ended double-strand breaks. This has been confirmed in rat thymus by use of ligation-mediated polymerase chain reaction (LM-PCR) methods (Staley et aI., 1997) . Contradictory views have been presented using DNA polymerase (Peitsch et aI., 1993) or synthetic oligonucleotides in an in situ hybrid ization histochemical approach with paraffin-embedded sections of rat thymus (Didenko and Hornsby, 1996) . Although the latter methods are not quantitative, it was suggested that the majority of fragment ends i n thymus has single-base 3' overhangs, although some blunt-ended fragments were also present (Didenko and Hornsby, 1996) . Alternatively, because DNA from glucocorticoid treated thymic lymphocytes was labeled by the Klenow fragment of DNA polymerase (which lacks nick translation activity), it was argued that some ends pro duced during apoptosis must have 3' -recessed ends (Peitsch et aI., 1993) .
The situation with respect to the ends of DNA frag ments in ischemic neurons has not been studied, but neu rons dying during fetal development clearly contain oli gonucleosomal DNA fragments in which a majority are blunt ended (Blaschke et aI., 1996) . However the ability of in situ end-labeling by the Klenow fragment of DNA polymerase I to detect DNA scission in neurons in brain sections from ischemic adult animals suggests the pres ence of 3'-recessed ends (Tobita et aI., 1995; Tagaya et ai., 1997) . We herein directly examine the nature of the ends of DNA fragments appearing after either global or focal cerebral ischemia in adult animals, or hypoxia ischemia in neonatal animals, and find them all different from those present in either ischemic myocardium, apop totic neurons in developing brain, or apoptotic cultured cortical neurons and human neuroblastoma. It is con cluded that the endonuclease responsible for degrading DNA into oligonucleosomal fragments in ischemic brain is not the same as that operating during classic apoptosis.
MATERIALS AND METHODS

Cerebral ischemia
Adult rat transient global ischemia by two-vessel occlusion.
All procedures involving animals received institutional ap proval and met the guidelines of the Canadian Council on Ani mal Care. Transient cerebral global ischemia by two-vessel occlusion was produced in pentobarbital-anesthetized male Sprague Dawley rats (350 to 400 g) by bilateral carotid artery occlusion combined with hypovolemic arterial hypotension for 12 minutes with careful maintenance of normal brain tempera ture (37.5° to 38°C) as described previously (MacManus et at., 1995) . After 48 hours of reperfusion when DNA fragmentation is maximal (MacManus et a!., 1995), the brain was sampled after sacrifice by decapitation under anesthesia with 3% flu othane, immediately chilled, and dissected on a cold plate (O°C), and the striatum was frozen and stored at -80°C until assay.
Adult rat transient focal ischemia. Mature male spontane ously hypertensive (SHR, 225 to 250 g) Wi star rats (Harlan Sprague-Dawley Inc., Indianapolis, IN, U.S.A.) were fasted for 18 hours before transient focal ischemia was produced by tem porarily clipping the middle cerebral artery (for 2 or 3 hours) as described by Buchan et at. (1992) . This procedure reduced regional cerebral blood tlow to 15% of basal level during the ischemic period and returned it to 95% of basal level on reper fusion. Brain temperature was controlled to 37.5° ± 0.5°C both during anesthesia and after recovery. After 24 hours of reper fusion when DNA fragmentation is easily detectable, rats were sacrificed, the brains were rapidly removed, and the right cor tex was dissected on a cold plate and stored at -80°e.
Neonatal rat hypoxia-ischemia. A period of cerebral hypoxi a-ischemia was produced in 7-day-old Wistar rats using a well established neonatal model of hypoxia-ischemia similar to that described previously (MacManus et at., 1997b) . Briefly, ani mals were anesthetized with isoflurane (4% for induction, 1.5% to 2.5% for maintenance), and the right carotid artery was isolated and ligated. A 2-to 3-hour recovery period with the dam was followed by 2 hours in a humidified hypoxic chamber (8% oxygen + 0.3% isoflurane for sedation; remainder nitro gen) that was maintained at 35.SOC, resulting in an axillary temperature of 36.5° to 37°e. The animals were then returned to the dam and 18 hours after the end of hypoxia, when DNA fragmentation was obvious (MacManus et at., 1997 b), were reanesthetized with pentobarbital (40 mg/kg) before sacrifice.
The brain was quickly removed and the cortex, striatum, and thalamus were dissected and frozen in isopentane (-60°C) and subsequently stored at -75°C until assay.
Cardiac ischemia
Cardiac ischemia was produced by coronary artery occlusion for 45 minutes in male Sprague-Dawley rats under halothane anesthesia as described previously (Fliss and Gattinger, 1996) .
After removal of the suture, reperfusion was continued for 4 hours, at which time the ischemic cardiac tissue was dissected after delineation by negative staining with Evans blue dye, rapidly frozen, and stored at -80°e. 
Cultured cells
DNA isolation and electrophoresis
The total DNA was extracted and purified by precipitation from brain samples or from cultured cells by standard methods, and then 3' -end labeled using terminal transferase before elec trophoresis as described (MacManus et aI., 1995) . Purification of discrete mononucleosomal DNA. When the discrete mononucleosomal DNA fragment was required, the total DNA (without 3' -end labeling) from ischemic adult or neonatal brain and ischemic heart was initially electrophoresed as outlined above, the gel was stained with ethidium bromide, and the monosome-sized fragment was excised from the gel.
This discrete DNA fragment was isolated from the gel medium using BioRad Prep-A-Gene DNA purification matrix (BioRad Inc., Mississauga, Ontario, Canada) following the manufactur er's instructions.
Ligation-mediated peR for blunt-ended DNA
The feasibility of using LM-PCR to detect the presence of blunt-ended DNA fragments (Staley et aI., 1997) was demon strated in our hands using A-DNA (purchased from Gibco BRL) and pBR322 plasmid DNA (isolated from Escherichia coli HB 1 01 grown in LB medium), which was purified using a QIAamp Plasmid Kit (QIAGEN Inc., Chatsworth, CA, U.S. A.) according to the manufacturer's instructions. Both blunt-ended and 3' -recessed fragments were produced from these purified DNA samples. A blunt-ended fragment (604 bp) was obtained The LM-PCR procedure was performed on DNA from both the test samples with blunt and recessed ends described above, and the various tissue samples as outlined (Staley et aI., 1997) . 
RESULTS
As demonstrated in the Chun laboratory (Staley et aI., 1997) , a method of LM-PCR can be designed that will only amplify blunt-ended DNA fragments, In Fig. 1 we confirmed this specificity using a blunt-ended fragment of '--DNA and showing that a 3' -recessed end of only 1 nt was sufficient to prevent PCR amplification. Blunt ending the fragments, which contained either 1-, 2-, or 4-nt recessed ends by use of Klenow DNA polymerase to fill in the missing nucleotides, now permitted amplifica tion (Fig. I) .
When this LM-PCR method was applied to extracts of adult thymic lymphocytes ( Fig. 2A) , we were able to corroborate its ability to easily detect laddered DNA fragments from apoptotic thymic lymphocytes. It should be noted that the size of the individual rungs of such laddered DNA fragments is increased by 48 bp because of addition of the PCR primer oligonucleotide to each end of the amplified fragment (Staley et aI., 1997) . Pre treatment of the DNA fragments with DNA polymerase to blunt end any existing recessed ends gave no increase in the intensity of band staining, suggesting that the vast majority of the fragments from the thymic lymphocytes were indeed blunt ended. To our surprise, there were few detectable laddered DNA fragments from ischemic adult brain, whether striatum ( Fig. 2B) or hippocampus (not shown) after transient global ischemia, or cortex (Fig.  2C ) or dorsolateral striatum (not shown) after transient focal ischemia. However, pretreatment of these brain DNA fragments with DNA polymerase permitted their amplification and ready detectability in the agarose gels ( Fig. 2B and C) , indicating that the majority of these fragments from ischemic adult brain were not blunt ended, but rather had ends with at least a l-nt 3' recess. The similarity in the intensity of the band staining pro duced from 8 pg of target DNA which had been poly merase pretreated to the intensity produced from 1,000 pg of target DNA without treatment ( Fig. 2B and C) led to the conclusion that more than 99% of the fragments induced by cerebral ischemia in the adult were not blunt ended. On the other hand, the fragments from ischemic myocardium did appear to be blunt ended ( Fig. 2D ) and
were as similarly insensitive to polymerase pretreatment as those from apoptotic thymic lymphocytes, indicating that the majority of the DNA fragments in injured myo cardium had different ends compared with those in the ischemic adult brain. The finding of fragments with recessed ends was ex tended to ischemic brain from day 7 neonatal animals subjected to hypoxia-ischemia (Fig. 3) . In DNA isolated from either hypoxic-ischemic cortex, striatum, or thala mus, the similarity in staining intensity of the amplified fragments from 8 to 40 pg of blunt-ended target DNA to that from 1,000 pg of original DNA again led to the conclusion that the majority of the fragments were not blunt ended. In contrast, when immature neurons from the neocortex of E 18 rats were cultured and induced to undergo apoptosis by staurosporine treatment, the ensu ing oligonucleosome-sized DNA fragments were easily detectable and were unaffected by blunt ending, suggest ing that few, if any, recessed ends were present (Fig. 4A ). Similar blunt-ended DNA fragments were found to pre dominate in apoptotic neuroblastoma cells (Fig. 4B) .
Finally, the LM-PCR method was used to determine the length of the 3' recess in the DNA fragments from ischemic brain. To simplify the subsequent analysis, we first isolated the monosome-sized DNA fragment from ischemic adult and neonatal brain and from ischemic myocardium, and then determined the size difference be tween the largest double-stranded monosomal fragment obtained by blunt ending (filling in the recess) with Kle now polymerase and the smallest double-stranded frag ment obtained with blunt ends obtained by removal of any unpaired 5' overhang with the single-strand-specific S 1 nuclease. The monomeric DNA does not electropho rese in tight bands because it is heterogeneous, but Fig.  5 still shows that a difference of approximately 20 bp exists in the mean size of the monosomal DNA frag ments from either ischemic adult or neonatal brain treated with polymerase compared with those treated with nuclease. It was concluded that a 3' -recess at either end of the double-strand DNA fragment of approxi mately 8 to 10 nt would explain such a finding. It could be argued that nuclease digestion would always lead to a smaller DNA fragment because in addition to removal of any overhanging unpaired DNA, it was possible that SI nuclease digestion could reduce fragment size by cleav ing into the double-stranded region. This was not ob served under the conditions used because the fragments from ischemic heart, which were considered blunt ended, did not change in size after treatment with S 1 nuclease or polymerase (Fig. 5) .
DISCUSSION
This study addressed the question of whether all elec trophoretically separated laddered DNA fragments are 1. P. MacMANUS ET AL.
T -lymphocytes
Global ischemia adult brain , 1995, 1997b ) and many others (re viewed by Choi 1996; Chopp and Li, 1996; Linnik, 1996; MacManus and Linnik, 1997) based solely on similar oligomeric patterns of 180 to 200 bp unit size. Such oligonucleosomal electrophoretic patterns are re garded as one of the hallmarks of an apoptotic mode of cell death (Wyllie et aI., 1980) . However, on closer in spection in the current study, these laddered DNA frag ments from ischemic neonatal or adult brain were shown to be different from those found during programmed cell death in immature brain, or classic apoptosis exemplified by either glucocorticoid-treated thymocytes or stauro sporine-treated cultured primary neurons or neuroblas toma. Despite the huge amount of work done in the last The majority of DNA fragments from apoptotic T lymphocytes are blunt ended and show no effect of polymer ase pretreatment. (8 and C) The ma jority of DNA fragments from ischemic brain are not blunt ended, but pre treatment with polymerase permits subsequent amplification. (0) The DNA fragments from ischemic myo cardium are predominantly blunt ended and do not benefit from poly merase pretreatment.
several years demonstrating laddered DNA fragmenta tion patterns in myriad cell types, relatively little infor mation has emerged as to the nature of the ends of these fragments. Dying thymocytes produced by glucocorti coid treatment remain one of the primary models for studies on apoptosis, and evidence has been presented that the DNA fragments appearing after such treatment are blunt ended (Alnemri and Litwack, 1990) , as are fragments in novobiocin-treated chicken erythrocytes (Villeponteau et aI., 1986) . Similar conclusions were reached using a semiquantitative LM-PCR method that depends on the presence of blunt-ended fragments, al though a small proportion of the thymocyte DNA frag ments may have 3' -recessed ends (Staley et aI., 1997) . The presence of some such 3' -recessed ends in gluco corticoid-treated thymic lymphocytes had previously (Peitsch et aI., 1993) . However, a com pletely opposite conclusion was reached in another re cent study, in which it was suggested that the majority of fragment ends in thymus have single-base 3' overhangs, although some blunt-ended fragments were also present (Didenko and Hornsby, 1996) . The methods used to gen erate these latter findings are not quantitative, so the LM-PCR method appears to produce the most reliable information owing to its semiquantitative nature. How ever, this leads to another dilemma in that if it i s accepted that blunt ends predominate in this classic model of ap optosis, then the endonuclease that produces them has few counterparts. Most known endonucleascs, especially the ones touted to be involved in apoptosis such as DN ase I and II, or Nuc 18 (Bortner et aI., 1995; Walker and Sikorska, 1997) , do not generate blunt-ended fragments (Lutter, 1977; Soliner-Webb et aI., 1978; Staley et aI., 1997) ; for example, DNase I and II produce double-++++ ++++ strand breaks with 3-or 4-nt 3' -overhang ends, not 3' recessed ends (Soliner-Webb et aI., 1978) . Our direct demonstration that the majority of laddered DNA fragments produced after either global or focal cerebral ischemia in adult brain has 3'-recessed ends is novel. However, it must be said that the use of Klenow DNA polymerase 1 (i.e., without the confounding activ ity of nick translation) to successfully label brain sec tions from ischemic animals had already suggested that such 3' -recessed ends were present (Tobita et aI., 1995; Tagaya et aI., 1997) . The massive programmed cell death of neurons during late fetal and early neonatal develop ment is considered to be apoptotic on the basis of both morphologic and DNA fragmentation criteria (Ferrer et aI., 1994; Lo et ai., 1995; Blaschke et aI., 1996; Portera Cailliau et ai., 1997a) . Both cultured cortical neurons (MacManus et ai., 1 997a) or human neuroblastoma SH SY5Y (Posmantur et aI., 1997) induced to die by stau rosporine treatment also exhibit morphologic and bio- emic adult and neonatal brain is 8 to 10 nt. The monosomally sized DNA fragment isolated from total DNA of ischemic adult or neonatal brain and ischemic heart was blunt ended by treatment with either Klenow polymerase or single-strand-specific S1 nuclease before amplification by LM-PCR. The center of the DNA bands is indicated for each treatment, and is approximately 20 bp lower after nuclease treatment from both ischemic adult and neo natal brain. The size of the monosomal DNA from ischemic heart was unaffected by either treatment, confirming its blunt-ended nature, a fact that also demonstrates the specificity of the S1 nuclease reaction.
chemical hallmarks of classic apoptosis. The laddered DNA fragments from both these apoptotic models were likewise found to be blunt ended (Fig. 4) , in addition to those from the archetypal apoptotic adult thymocytes in duced to die by glucocorticoid ( Fig. 2A) . In contrast, the majority of oligonucleosomal DNA fragments from isch emic adult or neonatal brain are not blunt ended but contain 3'-recessed ends ( Fig. 2B and C, and 3) . In the global model of ischemia at the 48-hour reperfusion time chosen, we conclude that the majority of DNA fragments originate in striatal neurons (MacManus et aI., 1995) , but in both the adult focal and the neonatal hypoxia ischemia models, with the relatively long periods of isch emia, cell death is nonselective, and it is concluded that the DNA fragments arise from both neurons and glia in the infarcted tissue. It remains to be seen whether mild J Cereb Blood Flow Metab. Vol. 19, No.5, 1999 ischemia, which produces visible apoptotic neurons after much longer reperfusion times than used in the current study (Du et aI., 1996; Endres et aI., 1998) , gives rise to DNA fragments with blunt or staggered ends. On the other hand, the majority of laddered DNA fragments from ischemic myocardium are blunt ended (Fig. 2D) , indicating that not all ischemic tissue generates DNA fragment ends different from archetypal apoptosis. This similarity of the DNA fragmentation of ischemic heart to classic apoptosis supports the conclusions in animal and human ischemic myocardium in which both morphologic and biochemical evidence of apoptosis has been ob served (Fliss and Gattinger, 1996; Veinot et aI., 1997) . There has been intense debate about whether the neu ronal death after an episode of cerebral ischemia is ne crotic or apoptotic. Morphologic evidence has been lack ing at the ultrastructural level in both global and focal models of cerebral ischemia (Deshpande et aI., 1992; van Lookeren-Campagne and Gill, 1996; Petito et aI., 1997) , although after focal ischemia apoptotic morphology has been reported primarily in the inner border zone of the ischemic infarct (Li et aI., 1995) and in the hippocampus after global ischemia (Nitatori et aI., 1995) . At the simple light microscopic level some evidence of chromatin mar gination and karyorrhexis has been observed both within and outside the infarct zone (Charriault-Marlangue et aI., 1996; Endres et aI., 1998; Li et aI., 1995; States et aI., 1996) that is reminiscent of the appearance of dying neurons during programmed cell death in fetal and post natal development (Lo et aI., 1995) . In addition to the morphologic criteria and the biochemical hallmark of oligonucleosomal DNA fragmentation discussed above, other biochemical hallmarks of apoptosis have been re ported after cerebral ischemia, particularly the expres sion of proapoptotic genes such as p53, bax, and myc (reviewed by Koistinaho and Hokfelt 1997; MacManus and Linnik, 1997) and the activation of proteolytic caspases Namura et aI., 1998) .
The current finding that the low-molecular weight DNA fragments appearing in neonatal or adult brain after ischemia are different from archetypal apoptosis adds support to the suggestion, found with the high-molecular weight DNA fragments (MacManus et aI., 1997b) , that ischemic cell death of neurons is not by apoptosis as originally defined, i.e., type I (Wyllie et aI., 1980; Clark, 1990) . However, it is not by necrosis either, because such degeneration in brain leads to random fragmentation of DNA that appears as electrophoretic smears (Tominaga et aI., 1993; MacManus et aI., 1995) . Indeed, the distinc tion between apoptosis and necrosis may be somewhat artificial and needs to be replaced by an expanded view, with more or less of the core cell-death machinery being engaged, and perhaps controlled by the cellular A TP level (Leist and Nicotera, 1997) . In a most thorough study on excitotoxicity in immature and adult brain, the provocative suggestion was made that a continuum exists in the damaged brain between apoptosis and necrosis (Portera-Cailliau et aI., 1997 a, 1997 b). It has also been suggested that the occurrence of apoptosis or necrosis is dependent on the severity of the insult determined by the duration or level of the ischemia, or whether cell death is in the core or periphery of the damaged territory (Du et aI., 1996; Endres et aI., 1998; Li et aI., 1995; Matsushita et aI., 1998) . In addition, it may be that characteristics of both can occur in the same cell, as in a study of brain trauma in which evidence was presented for apoptosis with nuclear characteristics but necrosis with cytoplas mic characteristics (Colicos and Dash, 1996) . Thus, at tempting to distinguish between the black and white defi nitions of cell death by apoptosis or necrosis is an over simplification and not sufficient to describe the processes involved in cerebral ischemic cell death. Instead, re sponses to different types of injury and their divergence from archetypal type I apoptosis and developmental pro grammed cell death will need to be assessed indepen dently.
Our studies will evolve to identify the endonuclease that leaves the footprint of both 3' -and 5' -OH end groups in high-molecular weight DNA fragments (Mac Manus et aI., 1997b) and the footprint of low-molecular weight laddered DNA fragments with 8-to lO-nt 3' recessed ends (Figs. 2, 3 and 5). The combipation of endonucleases that cause such complex scission of the DNA backbone needs to be identified before any mecha nism of cell death, whether apoptotic, necrotic, or par ticularly ischemic, can be formulated and targeted for therapeutic intervention.
